Fraser MacDonald
Directeur/Bestuurslid bij PHARMALA BIOTECH HOLDINGS INC.
Vermogen: 15 800 $ op 30-04-2024
Profiel
Fraser MacDonald is currently an Independent Director at Pharmala Biotech Holdings, Inc. and a Director at Pharmala Biotech, Inc. He completed his undergraduate degree at Queen's University and his graduate degree at Bond University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-02-2024 | 100 000 ( 0.12% ) | 15 800 $ | 30-04-2024 |
Actieve functies van Fraser MacDonald
| Bedrijven | Functie | Begin |
|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Bestuurslid | 21-03-2021 |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Opleiding van Fraser MacDonald
| Queen's University | Undergraduate Degree |
| Bond University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
